Using a digital advertising strategy is now largely the default option for most organizations, outside of a few very niche markets. The benefits offered...
Sarepta Therapeutics (NASDAQ:SRPT) is a large (~$14 billion market cap) biopharmaceutical company that markets 3 RNA-targeted products for Duchenne muscular dystrophy (DMD) patients. In...